What clinical trials are currently recruiting in South Dakota?

TrialFinder lists 325 recruiting clinical trials with sites in or near South Dakota. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in South Dakota?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in South Dakota?

Trials in South Dakota cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in South Dakota?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

325 Recruiting Trials

Clinical Trials in South Dakota

Browse 325 recruiting clinical trials currently enrolling participants in South Dakota. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 325 recruiting trials in South Dakota

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

Perform Humeral System Study

N/A Lexington, Kentucky +4 sites · Osteoarthritis Shoulder, Rotator Cuff Tear Arthropathy

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

PHASE3 Birmingham, Alabama +4 sites · Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma

Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Myelodysplastic Syndrome

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

Alleviant ALLAY-HF Study

NA Phoenix, Arizona +4 sites · Heart Failure

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

PHASE2 Birmingham, Alabama +4 sites · Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

PHASE3 Little Rock, Arkansas +4 sites · Non Small Cell Lung Cancer

Recruiting

Investigations of Reproductive Cancers in Women

N/A Birmingham, Alabama +4 sites · Uterine Cancer

Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

PHASE4 Birmingham, Alabama +4 sites · Crohn's Disease, Ulcerative Colitis

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

PHASE3 Mobile, Alabama +4 sites · Non-squamous Non-small Cell Lung Cancer

Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

PHASE3 Daphne, Alabama +4 sites · Extensive-Stage Small Cell Lung Cancer

Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

PHASE3 Mobile, Alabama +4 sites · Diffuse Large B-Cell Lymphoma

Recruiting

Alleviant ALLAY-HFrEF Study

NA Los Angeles, California +4 sites · Heart Failure

Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

PHASE2 Birmingham, Alabama +4 sites · Neoadjuvant, Epithelial Ovarian Cancer

Recruiting

See all 325 results in South Dakota

Check Your Eligibility

Create a free profile and our AI will match you to trials in South Dakota you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in South Dakota

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon